GlobeNewsWire
27 Oct 2026, 20:48 UTC · 2h ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines – HIMS
Impact · against what's priced in
The announcement of a class action lawsuit is not a catalyst for HIMS. The current price already reflects significant legal friction and refuses to assume a clean resolution to existing litigation.
- HIMS−0.05
Already priced in
- The price assumes
Significant legal and regulatory friction, including FTC lawsuits over data privacy and billing practices.





